PT - JOURNAL ARTICLE AU - Valia, Daniel AU - Ingelbeen, Brecht AU - Kaboré, Bérenger AU - Karama, Ibrahima AU - Peeters, Marjan AU - Lompo, Palpouguini AU - Vlieghe, Erika AU - Post, Annelies AU - Cox, Janneke AU - de Mast, Quirijn AU - Robert, Annie AU - van der Sande, Marianne A.B. AU - Villalobos, Hector Rodriguez AU - van der Ven, Andre AU - Tinto, Halidou AU - Jacobs, Jan TI - Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso AID - 10.1101/2021.02.24.21252387 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.24.21252387 4099 - http://medrxiv.org/content/early/2021/02/25/2021.02.24.21252387.short 4100 - http://medrxiv.org/content/early/2021/02/25/2021.02.24.21252387.full AB - Background In low- and middle-income countries (LMIC), the prevalence of antimicrobial resistance (AMR) is increasing. WHO recommends monitoring antibiotic use, in particular Watch antibiotics, clinical important but at risk of becoming ineffective due to increasing AMR. We investigated antibiotic use at primary care or community-level in rural Burkina Faso.Methods During 2016-2017, patients aged >3 months admitted with severe acute fever to the rural hospital of Nanoro Health District, Burkina Faso, reported antibiotic use in the two weeks prior to consultation or hospitalization, which we analysed using the WHO Access, Watch, Reserve (AWaRe) classification. Most Watch antibiotics, e.g. ceftriaxone, are not recommended at primary health center level, as is also the case for ciprofloxacin in children.Results Of 920 participants (63.0% ≤14 years), pre-admission antibiotic use was reported by 363 (39.5%) of whom 58 (16.0%) reported more than one antibiotic. Use was more frequent among health center referrals (231, 54.0%) than among self-referred patients (131, 26.7%, p<0.001). Of 424 antibiotics, 261 (61.6%) were Access and 159 (37.5%) Watch antibiotics. Watch antibiotics use was more frequent among >14 year olds (72, 51.1%) than 0-14 year olds (87, 30.7%) and among referrals (41, 28.1%) compared to self-referred patients (117, 42.2%). Most frequently used Watch antibiotics were ceftriaxone (114, 26.9%) and ciprofloxacin (32, 7.5%). Among antibiotics reported by referral patients, ceftriaxone and ciprofloxacin were respectively recorded 100 (36.1%) and 12 times (4.3%).Conclusion The frequent use of Watch group antibiotics prior to presentation to the hospital in rural Burkina Faso highlights the need to address primary care, over-the-counter and informal community-level antibiotic use as part of antibiotic stewardship in LMIC, facilitating referral, access to qualified prescribers, or improving diagnostic tools in health centers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work, neither by the authors nor by their institutionsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The PaluBac study protocol and an amendment to include pre-admission antibiotic use were approved by the Ethics Committee for Health Research of Burkina Faso (ref 1029/15 and 2017-01-001)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used for the different analyses in the manuscript are available and may be share if needed